Ted Yednock
Chief Tech/Sci/R&D Officer at ANNEXON, INC.
Net worth: 670 187 $ as of 30/03/2024
Profile
Ted Yednock is currently the Chief Innovation Officer at Annexon, Inc. He previously worked as the Executive Vice President & Head-Global Research at Elan Corp.
Plc from 2005 to 2014.
Prior to that, he was a Scientist at Athena Neurosciences LLC from 1990 to 1996.
From 1996 to 2013, he served as the Head-Global Research at Elan Pharmaceuticals LLC.
Dr. Yednock also holds the position of Chief Scientific Officer at Prothena Corp.
Plc.
He completed his undergraduate degree at the University of Illinois in 1979 and obtained his doctorate from The University of California, San Francisco in 1986.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ANNEXON, INC.
0.10% | 19/02/2024 | 93,471 ( 0.10% ) | 670 187 $ | 30/03/2024 |
Ted Yednock active positions
| Companies | Position | Start |
|---|---|---|
| ANNEXON, INC. | Chief Tech/Sci/R&D Officer | 31/10/2013 |
Former positions of Ted Yednock
| Companies | Position | End |
|---|---|---|
Elan Corp. Plc
 Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Chief Tech/Sci/R&D Officer | 23/04/2014 |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 31/12/2012 |
Athena Neurosciences LLC
 Athena Neurosciences LLC Miscellaneous Commercial ServicesCommercial Services Athena Neurosciences LLC operates as a research-based pharmaceutical company committed to the field of neurology. It develops therapeutic and diagnostic products. The company was founded by David Rowley-Jones, Larry C. Fritz, and Larry A. Bock in 1986 and is headquartered in Allegan, MI. | Corporate Officer/Principal | 31/12/1995 |
| PROTHENA CORPORATION PLC | Corporate Officer/Principal | - |
Training of Ted Yednock
| University of Illinois | Undergraduate Degree |
| The University of California, San Francisco | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ANNEXON, INC. | Health Technology |
| PROTHENA CORPORATION PLC | Health Technology |
| Private companies | 3 |
|---|---|
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Health Technology |
Athena Neurosciences LLC
Athena Neurosciences LLC Miscellaneous Commercial ServicesCommercial Services Athena Neurosciences LLC operates as a research-based pharmaceutical company committed to the field of neurology. It develops therapeutic and diagnostic products. The company was founded by David Rowley-Jones, Larry C. Fritz, and Larry A. Bock in 1986 and is headquartered in Allegan, MI. | Commercial Services |
Elan Pharmaceuticals, LLC
Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Ted Yednock
